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SUMMARY
Epidermal homeostasis requires balanced progenitor
cell proliferation and loss of differentiated cells from
the epidermal surface. During this process, cells un-
dergomajor changes in their transcriptional programs
to accommodate new cellular functions. We found
that transcriptional and post-transcriptional mecha-
nisms underlying these changes jointly control
genes involved in cell adhesion, a key process in
epidermal maintenance. Using siRNA-based pertur-
bation screens, we identified DNA and/or RNA
binding regulators of epidermal differentiation.
Computational modeling and experimental validation
identified functional interactions between the matrin-
type 2 zinc-finger protein ZMAT2 and the epigenetic
modifiers ING5, SMARCA5, BRD1, UHRF1, BPTF,
and SMARCC2. ZMAT2 is an interactor of the pre-
spliceosome that is required to keep cells in an
undifferentiated, proliferative state. RNA immuno-
precipitation and transcriptome-wide RNA splicing
analysis showed that ZMAT2 associates with and
regulates transcripts involved in cell adhesion in
conjunction with ING5. Thus, joint control by splicing
regulation, histone, and DNA modification is impor-
tant to maintain epidermal cells in an undifferentiated
state.
INTRODUCTION
As our understanding of gene expression regulation improves,
so does our awareness of its complex dynamics and timing.
The transcription machinery and its co-factors, chromatin state,
RNA splicing, and microRNAs (miRNAs) are only some of the
myriad of processes contributing to the versatile functions of a
cell. Regulation of gene expression is of particular importance
for governing the delicate balance between proliferation and dif-
ferentiation in stratified epithelial tissues such as the skin, breast,
or intestine. The high renewal rate in these tissues requires tight
regulation of gene expression programs to avoid the generation
of aberrantly behaving cells giving rise to diseases. Here, we use
primary human keratinocytes as a model to study the regulation
of gene expression programs governing epidermal proliferation
and differentiation. The epidermal layer of the skin is completely
replenished each month in a process driven by epidermal stem
cells (keratinocytes), which reside attached on the basal mem-
brane. Upon initiation of differentiation, these cells stop prolifer-
ating, release their integrin anchors, and move through the
different layers of the skin, traveling upward through the spinous
and the granular layers (Moreno-Layseca and Streuli, 2014).
Eventually, they end up denucleated and heavily interconnected
in the cornified layer, where they are shed from the surface. This
process is marked by, among others, downregulation of integ-
rins and upregulation of differentiation genes such as envoplakin
(ENV), periplakin (PPL) (Ruhrberg et al., 1997), involucrin (INV),
and transglutaminase 1 (TGM1) (Eckert et al., 2005). Throughout
this transition they continuously change and fine-tune their
expression programs using transcriptional and post-transcrip-
tional processes in a differentiation state-dependent manner.
These transitions in gene expression programs are controlled
by regulatory mechanisms provided by epigenetic factors, tran-
scription factors, and post-transcriptional processes such as
splicing. Epigenetic factors regulate chromatin accessibility
through remodeling (BPTF, SMARCA5) or by adding or removing
histone or DNA modifications (ING5, UHRF1) (Mulder et al.,
2012). Open chromatin structures allow for transcription factors
to bind their motifs and enable activation of gene expression pro-
grams. There are several transcription factors that have a known
role in keratinocyte biology (AP1, ETS family [Eckert et al., 1997;
Nagarajan et al., 2010]) to regulate the expression of differentia-
tion markers (e.g., IRF6 [Biggs et al., 2012; Botti et al., 2011] and
MAFB [Miyai et al., 2016]). The emerging RNA transcript is then
found by RNA-binding proteins that edit and protect it on its
way to being translated into a protein. One of the most important
RNA editing processes is RNA splicing, in which introns are
excised from the immature transcript, generating a mature
RNA transcript. More extensive editing via alternative splicing
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may be important in the skin, as there are several genes that
display isoform specific expression in different keratinocyte
cell states. For instance, dermokine, a gene that is highly ex-
pressed in the granular layer of the epidermis, is heavily spliced,
generating multiple isoforms with different functions (Naso et al.,
2007). Another example is desmoplakin (DSP), which has two
major isoforms that seem to have distinct functions in controlling
desmosomal adhesion in the skin (Cabral et al., 2012). These
examples illustrate the importance of proper regulation of both
transcriptional and post-transcriptional processes. However,
our current understanding of how these processes coordinately
govern epidermal biology is limited.
Here, we investigated the role of 145 putative DNA and/or
RNA binding factors in human epidermal differentiation using
small interfering RNA (siRNA)-based perturbation screens. We
identified the matrin type-2 zinc-finger protein ZMAT2 as being
important to maintain cells in an undifferentiated state and
as a splicing regulator of adhesion-related transcripts. More-
over, computational predictions and experimental validation
uncovered a previously unappreciated connection between
epigenetic and post-transcriptional control of keratinocyte
differentiation.
RESULTS
Gene Perturbation Screens Identify Nucleic Acid-
Binding Proteins Involved in Human Keratinocyte
Renewal and Differentiation
To investigate the role of putative nucleic acid-binding factors in
the regulation of epidermal stem cell renewal and differentiation,
we performed siRNA-based knockdown screens (Figure 1A). For
this, we selected 145 genes based on their expression levels in
keratinocytes (reads per kilobase million [RPKM] >5), differential
expression during differentiation (Figures S1A and S1B) (Kou-
wenhoven et al., 2015), and DNA or RNA binding potential. To
test the contribution of these genes to the process of differenti-
ation, we silenced each gene using a pool of 3 independent
siRNAs in triplicate and subsequently induced differentiation.
Transfected cells were cultured in different conditions for 48 hr
to induce differentiation with the EGF inhibitor AG1478, BMP
2/7, a combination of these compounds, 10% fetal bovine
serum, and a vehicle control, as previously described (Mulder
et al., 2012). These treatments led to the robust induction of ter-
minal differentiation marker TGM1 (Mulder et al., 2012). Endog-
enous TGM1 protein was quantified using a fluorescent In-Cell
Figure 1. Gene Perturbation Screens Reveal Nucleic Acid Binding Factors Involved in Epidermal Differentiation
(A) Schematic setup of the screen; siRNA transfection (n = 20) is followed by induction of differentiation (n = 3, 5 conditions, 48 hr) and quantification of protein
levels of transglutaminase 1.
(B–F) Volcano plots describing the effects of siRNA-based perturbation on transglutaminase 1 (TGM1) protein expression (x axis) and their significance (y axis)
(n = 3) in vehicle (B), AG1478 (C), BMP2/7 (D), AG1478+BMP2/7 (E), and serum (F) treatment conditions. Data from chromatin factors (CFs) are displayed
in red and nucleic acid (NA) binding factors in blue. Bars on top of graphs indicate spread of Z scores for each condition. FDR 0.001 (Benjamini-Hochberg).
Differentiation induced for 48 hr using the indicated treatments (vehicle control, AG1478, BMP 2/7, AG1478 + BMP 2/7, serum).
(G) The top 5 most significant genes in each condition, of which knockdown results in down- or upregulation of transglutaminase 1 levels in the 5 different
conditions. Significance is added as log10(p value).
See also Figures S1 and S2.
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Western assay with an antibody (BC.1), whose specificity was
confirmed using 2 independent siRNAs (Figure S1C). To account
for differences in cell number among the knockdown populations
in the screen, TGM1 measurements were normalized on DNA
content (DRAQ5 signal) for each well. After Z score transforma-
tion, the results were compiled into a single dataset covering
all 145 genes, 5 conditions, and replicates (Data S1). High corre-
lation between replicates highlighted the reproducibility of our
findings and the quality of our dataset (Figure S1D). Using a
random selection of 11 genes, we estimated the median knock-
down efficiency to be 88% (range: 28%–93%) and the false-
negative rate at <10% (Figure S1E). In addition, we performed
deconvolution experiments in which the individual siRNAs were
tested in parallel with the pool of 3 siRNAs that was used in the
screen. This indicated that 71%–87% of the siRNA pools con-
tained at least 2 siRNAs that recapitulated screen results (Fig-
ure S1F), which argues against widespread off-target effects.
Our dataset constitutes a high-quality resource of nucleic acid
binding factors to further characterize for their role in epidermal
self-renewal and differentiation.
From these data we identified putative nucleic acid binding
factors that significantly affected TGM1 levels (Benjamini-Hoch-
berg [BH] false discovery rate [FDR] p < 0.001) compared to the
average across all siRNAs in the screen in any of the conditions
(Data S1; Figures 1B–1F, blue datapoints). The normalized effect
size per gene is plotted on the x axis, whereas the statistical sig-
nificance is depicted on the y axis. These representations of the
data highlight the factors that modulate differentiation in the top
left and top right quadrants, respectively. Notably, the effects
and significance of individual factors were condition dependent,
indicating that not all identified factors play equivalent roles in the
different conditions tested (Data S1; Figure S2A). This is repre-
sented by the partial correlation between the effect sizes across
the conditions (Figure S2A, scatterplots in bottom half) and the
significant differences when comparing different conditions (Fig-
ure S2A, volcano plots in top half). In total, our screens revealed
57 genes that display a significant effect in at least 1 of the
conditions (Data S1), indicating that our experiments identified
factors that have a potential regulatory role in keratinocyte
differentiation.
To explore these individual hits, we selected the top 5 most
significant genes (Benjamini-Hochberg FDR p < 0.001) for each
condition (Figure 1G). These represent 21 distinct nucleic acid
binding factors, one-third of which (7) have previously been
implicated in epidermal renewal and/or differentiation, confirm-
ing the validity of our approach (Nagarajan et al., 2010; Botti
et al., 2011; Kolev et al., 2008; Tsuji et al., 2018; van den Bogaard
et al., 2015; Mehic et al., 2005; Marthaler et al., 2017; Tribioli
et al., 2002; Bourke et al., 2017; Amendt et al., 2002; Albino
et al., 2012). We sought to experimentally verify that the TGM1
measurements in our screen represented bona fide differentia-
tion and not solely regulation of TGM1 levels. To this end, we
selected IRF6 and ETS1 as exemplars and used RT-qPCR as
an alternative readout of the expression of differentiation and
basal cell markers after siRNA-mediated silencing. IRF6 has
been shown to be important for the expression of genes critical
to epidermal differentiation (Botti et al., 2011). In addition, ETS1
is involved in keeping the cells in an undifferentiated state by re-
pressing genes involved in the formation of the cornified enve-
lope (Nagarajan et al., 2010). RT-qPCR analysis confirmed the
effects of the knock down of these genes on TGM1 protein levels
in our experiments (Figure S1G). Moreover, we found that
silencing IRF6 resulted in lower expression of the differentiation
markers PPL, ENV, and IVL, whereas ETS1 silencing resulted in
induction of these differentiation markers and a reduction in the
basal cell markers ITGA6 and ITGB1. This is in line with the liter-
ature in which IRF6 is thought to regulate differentiation and
ETS1 is important in the self-renewing state. These results also
confirm that the effects of silencing IRF6 or ETS1 in our screen
reflect the cellular differentiation state and not merely deregula-
tion of TGM1 expression.
ZMAT2 Maintains Epidermal Keratinocytes in an
Undifferentiated, Proliferating State
A powerful feature of the approach we took is that our siRNA-
based screen setup allows us to combine the current results
on 145 DNA and/or RNA binding factors with published data
characterizing 330 epigenetic regulators (Mulder et al., 2012).
Moreover, it enables us to use a previously developed Bayesian
statistical framework that reveals genes that functionally interact
(Wang et al., 2012). This means identifying sets of genes that
share functionality through the regulation of similar cell biological
processes—in this case epidermal differentiation. Applying this
statistical approach to a combined epigenetic and DNA and/or
RNA binding factor dataset should therefore allow identification
of functional interactions among these groups of genes, leading
to insights into their joint regulation of epidermal biology. The
data distribution and variation of the two datasets are highly
comparable, allowing us to combine them for further analysis
(Figures 1B–1F, boxplots, and S2B). This resulted in a rich data-
set comprising 473 genes describing their effects on the expres-
sion of TGM1 in 5 conditions. Application of the Bayesian
network algorithm to this joint dataset revealed strong predicted
functional interactions between ZMAT2, a matrin-type 2 like
zinc-finger with potential DNA or RNA binding capacity, and
components of a previously identified network of epigenetic
regulators involved in epidermal renewal (Mulder et al., 2012)
(Figures 2A and S3, full network). This subnetwork contained
multiple members of different protein complexes representing
diverse epigenetic mechanisms such as MORF complex mem-
bers ING5 and BRD1, NURF complex members BPTF and
SMARCA5, and SMARCC2 and UHRF1 (Mulder et al., 2012).
This implies that ZMAT2 plays a role in epidermal differentiation
in conjunction with these epigenetic modifiers.
These predicted functional interactions prompted us to func-
tionally characterize ZMAT2 further. RT-qPCR analysis showed
that silencing ZMAT2 in keratinocytes resulted in increased
expression of differentiation markers (PPL, EVPL, INV, TGM1)
and concordant downregulation of basal-cell markers ITGB1
and ITGA6 (Figure 2B). In addition, depletion of ZMAT2 resulted
in a strong reduction in the number and size of clones in the col-
ony formation assay (Figure 2C), reflecting a loss of cell renewal
and proliferation capacity. These effects were not associated
with increased cell death or the induction of apoptosis following
ZMAT2 depletion (Figures S4A and S4B). Furthermore, cell-
cycle analysis showed that there was no immediate defect in
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proliferation (72 hr post-siRNA transfection), indicating that the
decrease in colony number and size in the colony formation
assay (CFA) is caused by an effect on long-term proliferation
(Figure S4C). This is also recapitulated in 3D organotypic cul-
tures (Figure 2D), showing that knock down of ZMAT2 causes
a marked decrease in the number of proliferative cells (Ki67+
cells quantified by immunostaining) and a disorganized
epidermis compared to non-targeting control siRNA (siControl)
(Figure 2E, 2–4 independent cultures with 2 independent
siRNAs). These results indicated that ZMAT2 plays a role in
maintaining epidermal cells in an undifferentiated, proliferative
state and confirms our primary screen results.
ZMAT2 Functionally Interacts with Epigenetic
Regulators of Epidermal Cell Renewal
The Bayesian mixture model predicted that ZMAT2 function-
ally interacts with the epigenetic regulators ING5, SMARCA5,
BPTF, UHRF1, and BRD1. We aimed to confirm these predicted
interactions using a double knockdown strategy. In this way, true
functional interactions can be identified (Mani et al., 2008; Cos-
tanzo et al., 2010; Horn et al., 2011; Roguev et al., 2013) by
comparing the quantitative effects of combinatorial knockdowns
on global gene expression with effects that can be expected
based on the individual knockdown (Horn et al., 2011). In cases
in which 2 genes are functionally independent (i.e., do not func-
tionally interact), the observed phenotype in the double knock-
down is equivalent to the product of the individual knockdown
phenotypes, or, when working with log-transformed values, their
summed value (Mani et al., 2008; Costanzo et al., 2010; Horn
et al., 2011; Roguev et al., 2013). Using this ‘‘product rule’’ as
the null hypothesis (labeled ‘‘exp’’ for expected in Figure 3A), ge-
netic interactions are statistically defined as aggravating (when
the observed phenotype is greater than expected) or alleviating
(when the observed phenotype of the combined knockdown is
less pronounced than expected), respectively (Figure 3A). In
general, alleviating interactions occur between genes involved
in the same process and/or pathway, whereas aggravating inter-
actions tend to be associated with functionally redundant pro-
cesses (Costanzo et al., 2010; Roguev et al., 2013).
In previous work, we showed that the epigenetic regulators
within the predicted subnetwork (Figure 2A) display true func-
tional interactions (Mulder et al., 2012). Therefore, we decided
Figure 2. Bayesian Network Prediction Reveals a Functional Interaction Network between Epigenetic Factors and ZMAT2
(A) The significant subnetwork predicting functional interactions between epigenetic factors ING5, SMARCA5, SMARCC2, BRD1, BPTF, and UHRF1 and zinc-
finger ZMAT2. (n = 3, an empirical p value was determined using a bootstrapping approach).
(B) RT-qPCR based characterization (n = 3, average log2 over non-targeting control siRNA [siControl] ± SD) of siZMAT2 depleted keratinocytes (no additional
induction of differentiation was applied).
(C) Colony formation assays (n = 3, average ± SD) of ZMAT2-depleted cells.
(D) Left: RT-qPCR analysis of knockdown efficiency in 3D cultures. Right: immunofluorescent staining of 3D organotypic cultures cultured after transfection with
siZMAT2 (n = 3, average ±SD; blue represents Hoechst 33342, red represents KRT1, and green represents ColVII). Scale bar represents 50 mm. Asterisk indicates
morphologically disorganized epidermis.
(E) Quantification of Ki67+ basal cells per 100 mm (n = 3, average ± SD) in the transfected 3D organotypic cultures. p value calculated with 2-sided t test.
See also Figures S3 and S4.
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to experimentally test the predicted interactions between ZMAT2
and ING5, SMARCA5, BPTF, UHRF1, or BRD1 using a combined
knockdown approach. As a control, we included EZH2, which is
only peripherally associated with the epigenetic factors in this
network (Mulder et al., 2012). To obtain a detailed quantitative
phenotype representing the cell state, we performed RNA-
sequencing expression profiling after silencing each of these
epigenetic factors individually, as well as in combination with
ZMAT2. Two independent siRNAs targeting each gene were
used in all of the possible permutations in triplicate. We analyzed
a total of 156 knockdown samples using a modified CEL-seq2
method that enables high-throughput 30 end tag-counting RNA-
sequencing (see STAR Methods for details). It is important to
note that the relatively shallow RNA-sequencing we performed
does not allow us to directly interpret the molecular mechanisms
underlying these interactions, but it is powerful for the discovery
of functional interactions based on the obtained RNA expression
profiles. We examined the data using DESeq 2.0 and identified
transcripts that were significantly differentially expressed
(p < 0.05) compared to control siRNA-transfected cells. After
quality control and filtering (see STAR Methods), we labeled an
interaction alleviating or aggravating for each detected transcript
per interrogated combination. We identified the transcripts that
displayed a statistically significant genetic interaction based on
the product rule criteria, as explained above (Figure 3A, Benja-
mini-Hochberg FDR p<0.01). For each of the factors we silenced
in combination with ZMAT2, between 55 and 197 genes dis-
played such interactions, in which the peripherally associated
factor EZH2 showed only 17 functionally interacting transcripts
(Figure 3B). The vast majority (>95%, in all cases) of the identified
functional interactions were alleviating interactions (Figure 3C).
Moreover, these alleviating interactions were highly enriched
compared to randomly picked genes (Figure 3D). This suggests
that ZMAT2, ING5, SMARCA5, BPTF, UHRF1, and BRD1 func-
tion in a similar process and/or pathway to affect epidermal
biology. Next, we performed Gene Ontology (GO) term enrich-
ment analysis on the genes contributing to the observed func-
tional interactions and found an overrepresentation of factors
involved in cell adhesion, a process that is required for anchoring
epidermal stem cells to their niche (Figure 3E). These findings
Figure 3. ZMAT2 and the Epigenetic Factors Regulate Similar Processes in Epidermal Differentiation
(A) Schematic depiction of the definition of aggravating and alleviating functional interactions. obs, observed. exp, expected (statistical null model).
(B) Heatmaps visualizing differential expression within the different samples. Scale represents log2 fold-change over siControl. Multiple testing corrected
p < 0.01, two-sided t test.
(C) Distribution of the statistically significant aggravating and alleviating functional interactions for each of the combined knockdown experiments.
(D) Enrichment of alleviating interactions in functionally interacting transcripts compared to random. p value calculated using a hypergeometric test.
(E) Gene Ontology term analysis on the union of all significantly differentially expressed genes within the knockdown combinations (DAVID). Multiple testing
corrected p value calculated using a hypergeometric test. ER, endoplasmic reticulum.
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show that we were able to experimentally validate the predicted
functional interactions between these epigenetic factors and
ZMAT2 and that this group of genes jointly regulates an RNA
expression program linked to cell adhesion.
ZMAT2 Associates with the (Pre-)spliceosome in
Epidermal Keratinocytes
To gain insight into the potential molecular role of ZMAT2 in
epidermal cell biology, we identified the proteins it associates
with using immunoprecipitation and quantitative mass spec-
trometry (IP-MS; Figure 4A). Reminiscent of the epigenetic fac-
tors, the ZMAT2 protein localizes to the nucleus, as determined
by immunofluorescence microscopy (Figure S5A). Antibody
specificity was confirmed using siRNA-mediated knockdown,
resulting in decreased nuclear ZMAT2 staining (Figure S5A).
Next, we performed immunoprecipitation (IP) using control
immunoglobulin G (IgG) (non-targeting and background binding)
and antibodies targeting endogenous ZMAT2 from nuclear ex-
tracts in triplicate. Following IP, sample preparation, and desalt-
ing, these samples were subjected to label-free quantitative
mass spectrometry to identify associated proteins. The data
are represented as enrichment over IgG control versus the signif-
icance over the 3 replicates, with significant interactors located
in the right upper quadrant (Figure 4B). Both Gene Ontology
Figure 4. ZMAT2 Interacts with Compo-
nents from the Pre-spliceosome
(A) Schematic representation of the experimental
setup. Nuclear extract was prepared, one in which
IgG and ZMAT2 pull-downs were performed in
triplicate. The peptides were quantified using la-
bel-free mass spectrometry.
(B) Volcano plot displaying the physical interactors
of ZMAT2, with the log2 fold enrichment of ZMAT2
associated proteins over non-specific IgG-bound
proteins plotted against their significance (n = 3).
Multiple testing corrected p value calculated with a
2-sided t test.
(C) Gene Ontology term analysis (STRING) on
proteins associated with ZMAT2. Multiple testing
corrected p value calculated using a hypergeo-
metric test.
(D) STRING interactions versus experimentally
found interactions with their significance (as
calculated in B) displayed in blue.
See also Figure S5.
and protein interaction database analysis
of the interacting proteins revealed that
ZMAT2 interacts with components of the
(pre-)spliceosome (Figures 4C and 4D).
These findings are in line with recent cry-
oelectron microscopy (cryo-EM) struc-
tures of the budding yeast pre-spliceo-
some, showing that the putative ZMAT2
ortholog Snu23 associates with the B*
(pre-catalytic) complex (Plaschka et al.,
2017; Ulrich and Wahl, 2017). Our
biochemical experiments identifying
ZMAT2 as an interactor of the pre-spli-
ceosome in human keratinocytes, together with our screen and
validation analysis, implicate RNA splicing as a potential key
regulatory process in epidermal renewal and differentiation.
ZMAT2 Associates with a Subset of Cellular Transcripts
Involved in Epidermal Biology
Even though mRNA splicing is a ubiquitous process, we
wondered whether ZMAT2-containing spliceosomes display
selectivity toward specific transcripts or whether ZMAT2 is asso-
ciated with essentially all of the transcripts present in the cell. An
indication for a more selective role for ZMAT2 stems from the
observation that the ZMAT2 protein is expressed in a tissue-spe-
cific manner, whereas other pre-spliceosome components show
much more ubiquitous expression in the human body (Fig-
ure S5B). Another indication comes from the Gene Ontology
term analysis on the genes that are regulated by the functionally
connected genes in our double knockdown experiments, where
we found an enrichment of adhesion-related genes (Figure 3E).
To identify ZMAT2-associated transcripts, we performed RNA
IP-sequencing (RIP-seq) with non-specific control IgGs and
ZMAT2-specific antibodies from nuclear extracts. RNA-IPs
were performed in triplicate, and the isolated RNA was used
to generate RNA-sequencing libraries using the modified CEL-
seq2 protocol (Figure 5A). This specific form of library
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Figure 5. Adhesion-Related Transcripts Are Associated with ZMAT2
(A) Schematic representation of the experimental setup. Nuclear extract was prepared from non-differentiated cells, and the normal immunoprecipitation pro-
cedure was performed up to the wash steps. RNA was isolated directly from the beads and prepared for sequencing using CEL-seq2.
(B) RNA concentration samples before and after the immunoprecipitation (IP) procedure. Corrected for cell numbers, in nanograms per microliter (n = 3).
(C) Transcript diversity of the CEL-seq2 libraries after sequencing. Number of identified genes per 1,000 counts (n = 3).
(D) Volcano plot displaying the transcripts that are significantly enriched in the ZMAT2 IP sample over the IgG IP sample as called by DESeq 2.0. Inset represents
significant hits identified in the IgG sample (n = 3). Multiple testing corrected p value calculated with a 2-sided t test.
(E) qPCR validation of ZMAT2-associated transcripts in the IP samples showing the enrichment over the input sample (n = 3, average ± SEM).
(F) Expression of the ZMAT2-associated transcripts is differential during induction of differentiation using EGF inhibitor AG1478 (10 mM) and BMP 2/7 for 48 hr
(n = 3, average ± SEM).
(G) Expression of ZMAT2-associated transcripts upon silencing ZMAT2 (70% knockdown [KD], 5 days of culture), as determined via qPCR (n = 3, average ± SD).
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preparation focuses on polyadenylated transcripts and allows
analysis of the low amount of material retrieved after IP. To
assess the specificity of enrichment, the recovered transcripts
were compared to RNA-sequencing of the input material.
Although the same amount of input material for IgG and
ZMAT2 pull-downs was used, the IP with the ZMAT2 antibodies
yielded substantially more RNA compared to the control IgGs, as
can be expected from its association with the spliceosome (Fig-
ure 5B). The library transcript diversity (number of different tran-
scripts detected per 1,000 reads) of the RNAs associated with
the control IgGs was similar to that of the input, reflecting non-
specific interactions. In contrast, the diversity of the ZMAT2-
associated RNAs was lower, indicating that ZMAT2 associates
with a subset of the total available transcripts, rather than binding
RNAs indiscriminately (Figure 5C).
Next, we used statistical analysis (DESeq 2.0) to identify signif-
icantly enriched transcripts for both the IgG and the ZMAT2
samples. None of the RNAs identified in the control IgG IP were
significantly enriched compared to inputs, indicating that these
represented non-specific background interactions (Figure 5D,
inset). In contrast, nearly 100 transcripts were significantly en-
riched in the ZMAT2 pull-down (Figure 5D). We chose to use
the IgG data as a comparison for the ZMAT2 sample to ensure
that we were comparing samples that had been processed in
an identical fashion.Many of the transcripts that were specifically
and strongly associatedwith ZMAT2 are involved in cell adhesion
(e.g., ITGB1 [Levy et al., 2000], DSP [Cabral et al., 2012], DST
[Michael et al., 2014], and ROCK2 [Lock et al., 2012]) and prolif-
eration processes (e.g., AREG [Stoll et al., 2016]). Because both
the functional interaction and RNA-IP experiments point toward
regulation of adhesion, we decided to focus on these transcripts.
We selected 7 of these transcripts for validation by RNA-IP, fol-
lowed by RT-qPCR, and included glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) as a negative control. This confirmed
that all 7 transcripts are highly enriched in the ZMAT2pull-downs,
whereas GAPDH is not, confirming the selectivity of RNAs asso-
ciatedwith ZMAT2 (Figure 5E). The lack of enrichment ofGAPDH,
one of the most abundantly expressed transcripts, in the ZMAT2
pull-down indicated that the identified associations are not solely
based on transcript abundance.Moreover, of these 7 transcripts,
ITGB1, AREG, DSP, DST, and SPINK5 are differentially ex-
pressed during differentiation (Figure 5F), suggesting that at least
some of the ZMAT2-associated transcripts are also regulated at
the transcriptional level. However, ZMAT2 itself does not seem to
be involved in the regulation of their expression, because
silencing ZMAT2 does not affect the expression of ITGB1,
ROCK2, AREG, and DST. The mild differential expression of
KTN1 (downregulated) and DSP and SPINK5 (upregulated) are
likely an effect of ZMAT2 silencing on the differentiation state of
the cell (Figures 2B and 5G). These experiments indicate that
ZMAT2 associates, presumably through its interaction with the
pre-spliceosome, with a specific subset of transcripts in human
epidermal cells.
ZMAT2 Silencing Leads to Differential Exon Usage of
Selected Genes
To investigate whether ZMAT2 silencing affects splicing in our
cells, we performed full-length transcript RNA-sequencing on
ZMAT2 knockdown samples in triplicate (Figure 6A). We
included the ZMAT2 interacting pre-spliceosome component
SRSF1 as a positive control for the disruption of splicing (Fig-
ure 4B). Silencing SRSF1 is expected to lead to defects in
splicing because it is involved in the first steps of assembly of
the spliceosome by enhancing the binding of the U1 small
nuclear ribonucleoprotein particle (snRNP) on the pre-mRNA
(Kohtz et al., 1994). In addition, we analyzed samples in which
we induced differentiation (48 hr, AG1478 + BMP2/7), to put
our findings in the context of keratinocyte differentiation. DEX-
Seq (Anders et al., 2012) was used to calculate and statistically
assess differential exonic region usage for all identified tran-
scripts to detect altered splicing activity. This revealed that
ZMAT2 affects splicing, although fewer exonic regions are
affected in their splicing by silencing ZMAT2 compared to
silencing SRSF1 or induction of differentiation—0.12 versus
1.5% for SRSF1 and 4% after induction of differentiation,
respectively (Figure 6B). These are consistent with the notion
that that ZMAT2 regulates splicing of a more restricted set of
transcripts than SRSF1 and the set that is differentially spliced
in differentiation. Moreover, the majority of exonic regions that
are differentially spliced upon silencing of ZMAT2 are also differ-
entially spliced in differentiation (Figure 6C), indicating that
ZMAT2 is involved in mediating splicing events associated with
differentiation and that regulating splicing of specific subset of
genes plays a role in epidermal biology. In line with this, organo-
typic cultures of cells depleted of SRSF1 displayed an expanded
and disorganized epidermal layer, while also affecting prolifera-
tion as determined using Ki67 staining (Figures S6A–S6C). Thus,
silencing the spliceosome component SRSF1 (at least partially)
phenocopies ZMAT2-depleted epidermis (Figures 2C and 2D),
confirming the role of splicing regulation in epidermal biology.
Exon usage of nearly 200 transcripts was affected by both
ZMAT2 and SRSF1. Of these 200 transcripts, the exons that
were differentially regulated by these factors were predominantly
mutually exclusive (Figure 6D), further supporting the notion of
specific functions for ZMAT2 compared to the core pre-spliceo-
some component SRSF1 in epidermal keratinocytes. An exem-
plar of this is the DMKN gene, which we experimentally validated
using exon-specific RT-qPCR (Figures S6E and S6F). DMKN
plays an important role in epidermal cornification and is exten-
sively spliced during differentiation (Naso et al., 2007; Leclerc
et al., 2014). We observed altered usage of exonic regions in
the N-terminal part of the transcript in the absence of ZMAT2,
which is also differentially spliced upon the induction of differen-
tiation (Figures S6E andS6F). Notably, we also observed specific
ZMAT2- and SRSF1-dependent differentially spliced exonic re-
gions. This further confirms that the observed differential splicing
in the small interfering RNA targeting ZMAT2 (siZMAT2) samples
are likely ZMAT2 dependent, rather than general differentiation-
mediated splicing following ZMAT2 silencing.
To investigate whether there were differences in the usage
of specific splicing mechanisms between ZMAT2 and SRSF1,
we used the MISO package, which enables a differential splicing
analysis based on annotation files describing different splice
events. This did not reveal major differences in splicing mecha-
nisms (skipped exons [SEs], intron retention [RI], mutually
exclusive exons [MXEs], alternative 50splice sites [A5SSs], or
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alternative 30 splice sites [A3SSs]) affected by ZMAT2 compared
to SRSF1 (Figure S6D). Moreover, computational analysis did
not identify strong motifs specifically associated with ZMAT2-
dependent splicing events compared to SRSF1-mediated
splicing. Together, our experiments suggest that ZMAT2 regu-
lates exon usage of a specific subset of transcripts rather than
functioning as a global splicing regulator in epidermal stem cells.
We note that our splicing analysis is unlikely to be fully compre-
hensive, because there is a slight enrichment of high expressed
transcripts in our data, precluding the interrogation of low ex-
pressed genes.
Functionally Interacting Genes Jointly Regulate an
Expression Program Involved in Cell Adhesion
The above-presented results, together with the network predic-
tion and functional interaction experiments (Figures 2 and 3),
indicate that there is a link between epigenetic regulation and
ZMAT2-mediated splicing of genes involved in cell adhesion.
Consistent with these functional interactions, we found that the
transcripts that are affected in their exon usage upon ZMAT2
silencing are highly enriched (p < 108) in direct ING5 genomic
binding targets, one of the epigenetic factors in the functional
interaction network (Figure 6E) (Mulder et al., 2012), indicating
that these genes regulate similar processes. In contrast,
there was no clear evidence for overlap with genes marked by
DNA methylation or the heterochromatin-associated H3K27me3
histone modification. Moreover, only a slight enrichment
(p = 0.003) for targets of the key epidermal transcription factor
TP63 was found, suggesting that ING5 and ZMAT2 cooperate
to regulate an RNA expression program that is important for
epidermal biology. Notably, the gene program targeted by both
ZMAT2 and ING5 was further enriched in genes associated with
focal adhesion formation, a process that anchors epidermal
stemcells to their niche.Overall, weconclude that joint epigenetic
and splicing regulation of specific subsets of genes maintains
epidermal stem cells in a proliferative, undifferentiated state.
Figure 6. ZMAT2 Regulates a Similar Gene Set as the Functionally Interacting Epigenetic Factors through Modulation of RNA Splicing
(A) Schematic representation of the experimental setup. ZMAT2 or SRSF1 was silenced using siRNAs, and cells were grown for 5 days or differentiation was
induced (48 hr, AG1478 + BMP 2/7), after which RNA was isolated and sequencing libraries prepared. Analysis was performed using DEXSeq.
(B) Percentage of total detected differentially spliced exonic regions as determinedwith the DEXSeq package in samples transfected with siZMAT2 or siSRSF1 or
where differentiation was induced.
(C) Overlap differentially spliced exonic regions for samples transfected with siZMAT2 or siSRSF1 or where differentiation was induced. p values were calculated
with a hypergeometric test.
(D) Differential usage exonic regions, plotting the fold change over siControl versus siSRSF1 or siZMAT2 (average of n = 3). R, Pearson’s correlation.
(E) Differentially spliced genes after knockdown of ZMAT2 are enriched for the binding of ING5 (chromatin immunoprecipitation sequencing [ChIP-seq] data
[Mulder et al., 2012]) and keratinocyte master regulator TP63. Gene Ontology term analysis on these genes shows enrichment for focal adhesion-related terms.
p values were calculated with a hypergeometric test.
See also Figure S6.
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DISCUSSION
Our results indicate that regulation of cell-cell adhesion-related
transcripts is at least orchestrated by a set of chromatin-associ-
ated epigenetic regulators and a splicing component. We were
able to discover their joint contribution by considering how genes
cooperate in the regulation of gene expression programs, starting
from our siRNA-based screens. Through these experiments we
generated a rich dataset describing the roles of DNA and/or RNA
binding factors and epigenetic regulators in human epidermal
stem cell differentiation. The specific setup of the experiments
enabledus touseourpreviouslypublishednetworkBayesianalgo-
rithm that predicts functional relations between genes, transcend-
ing the annotation of a gene as a transcription factor, chromatin
modifier, or splicing factor and providing insight into how genes
and processes work together to shape epidermal biology. Using
this approach, we uncovered functional interactions between
chromatin factors representing different epigenetic mechanisms
and the uncharacterized zinc-finger-containing protein ZMAT2.
Through interactionproteomicsandRNA-sequencingapproaches
we found that ZMAT2 is involved in RNA splicing in epidermal ker-
atinocytes. Moreover, RNA interaction experiments revealed an
enrichment of adhesion-related genes, suggesting that there is a
targeted process involved. Thus far, we did not find evidence for
specific deregulated splicing mechanisms that could explain this
selectivity, nor could it be explained simply through transcript
abundance and/or occurrence of specific RNA motifs.
It is conceivable that ZMAT2 functions through fine-tuning the
splicingmechanismof a subset of genes, especially when consid-
ering the different steps involved in splicing and the potential role
for ZMAT2 in these. Splicing is an important post-transcriptional
mechanism that catalyzes the excision of non-coding parts in
pre-mRNA transcripts or, in alternative splicing, the exon compo-
sition in amaturemRNA transcript. It is regulated by the large and
dynamic spliceosome complex, which facilitates the different
steps of the splicing reaction through rearrangements in protein
composition for each step. In the first step, the so-called complex
A recognizes the splice site, after which complex B is assembled.
This complex is catalytically activated to theB* complex via the in-
termediateBact complex. TheB* complex catalyzes the first trans-
esterification reaction and, after more rearrangements, generates
complex C, which catalyzes the second transesterification reac-
tion. The spliceosome is then disassembled and the subunits
are recycled. ZMAT2 is an interactor of theBcomplex,where it ac-
companies the core complex B component tri-snRNP U4/U6.U5.
Inyeast, this tri-snRNP isalreadyassociatedwithZMAT2homolog
Snu23 and pre-mRNA processing factor 38 (Prp38) strictly before
integration into the yeast pre-spliceosome (Plaschka et al., 2017).
In contrast, in humans these 2 proteins are recruited indepen-
dently from the tri-snRNP and are therefore considered non-
snRNP proteins. There are 7 more of these non-snRNP proteins
in humans (Ulrich andWahl, 2017),which are referred to asB-spe-
cific proteins. Although some of these proteins can influence
splice-site selection (e.g., Smu1, RED) (Spartz et al., 2004), their
exact function is not known. It is interesting to consider these pro-
teins asmediators of alternative splicing through the recognitionof
different splice sites, which may explain the observed enrichment
for adhesion-related genes for ZMAT2. However, even though the
interaction of ZMAT2 with the human spliceosome seems less
stringently required than it is in yeast, it may have an important
function in enabling more general conformational changes from
theB to theCcomplex. In yeast,Snu23 is thought to influenceacti-
vation of the Brr2 helicase via its stabilization on the U4 snRNA,
which is part of the U4/U6.U5 tri-snRNP. The Brr2-mediated un-
winding of the U4/U6 duplex is an important step toward gener-
ating a catalytically active spliceosome because it frees the U6
snRNA to form an internal loop with the U2 snRNA. This enables
the conformational changes needed for the branching step and
subsequent exon ligation (Plaschka et al., 2017). It is possible
that ZMAT2 transiently interacts with the human spliceosome to
facilitate and fine-tune these transitions. If this is the case, then
the timing of its association with the spliceosome may influence
the efficiencies of competing splicing mechanisms, spliceosome
composition, or conformation (Ulrich and Wahl, 2017). Although
we can only speculate about the exact molecular mechanisms
behind our observations at this point, the combined evidence
from our proteomic data and the literature implicates ZMAT2 as
a regulator of RNA splicing in epidermal stem cells.
Our results suggest that cell-cell adhesion is regulated by
a previously unanticipated connection between transcriptional
processes and post-transcriptional regulation. Experiments
investigating the functional interactions between epigenetic
modifiers and ZMAT2 revealed mostly alleviating interactions,
stressing the importance of proper splicing in conjunction with
epigenetic control of adhesion-related transcripts.We confirmed
these connections experimentally by showing that the genes
whose transcripts were differentially spliced upon silencing of
ZMAT2 were enriched for the binding of ING5. Moreover, these
genes were also enriched for the binding of p63, indicating that
the functionally connected genes are in charge of regulating a
gene set that is essential for epidermal biology. Considering
the importance of proper regulation of adhesion signaling for
maintaining the stem cell fate (Levy et al., 2000), it is not surpris-
ing that incorrect regulation leads to the severe effects observed
upon silencing these genes individually. This in combination with
the profound effect of silencing ZMAT2 individually on the differ-
entiation state of the cells shows that the fine-tuning of splicing
by ZMAT2 is of the utmost importance for keratinocyte biology.
We have discovered that this group of epigenetic modifiers
and ZMAT2 represent important hubs in the regulation of adhe-
sion-related transcripts and may be interesting to study more
mechanistically in light of epidermal differentiation. We conclude
that epigenetic and splicing factors jointly regulate processes
that are essential for epidermal biology. Our work provides in-
sights into the regulation of epidermal differentiation and high-
lights the importance of cooperation among disparate cellular
processes in the regulation of cell behavior.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Primary human foreskin keratinocytes were obtained from Lonza (00192906). They were cultured on a mitotically inactivated J2-3T3
layer as described previously (Mulder et al., 2012). Prior and during experiments where differentiation was induced, the cells were
grown on keratinocyte serum-free medium (KSFM, GIBCO) supplemented with 0.2 ng/mL epidermal growth factor (EGF, GIBCO)
and 30 ug/mL bovine pituitary extract (BPE, GIBCO). Differentiation was induced using 10 mM AG1478 (Calbiochem), 200 ng/mL
human recombinant BMP 2/7 (R&D systems) a combination of these or 10% fetal bovine serum (MP Bio) was added to the KSFM
for 48 hours.
For colony formation assays, J2-3T3 cells were seeded at 100.000 cells per well in a 6 well format and inactivated using mitomycin
C (2 mg/mL, Santa Cruz Biotechnology) as described previously (Mulder et al., 2012). Transfected keratinocytes (500 cells) were
seeded on top and grown for 2 weeks before fixation and immunostaining.
For 3D cultures, pooled primary human foreskin keratinocytes from different donors were obtained from PromoCell and grown
in a 1:1 mixture of KSF-M (GIBCO) and Medium 154 for keratinocytes (GIBCO), supplemented with Human Keratinocyte Growth
Supplement, epidermal growth factor, bovine pituitary extract and 1x Antibiotic-Antimycotic (all supplements from GIBCO).
METHOD DETAILS
siRNA nucleofection
Passage 3 lip or foreskin keratinocytes were grown to 70% confluency in KSFM before they were used for nucleofection using the
Amaxa system (Lonza). The cells were collected and resuspended in cell line buffer SF at 2*10^ 5 cells per 18 uL, mixed with 2 uM
siRNA. After transfection using program FF113, the cells were incubated for 10 minutes at room temperature. Finally, the transfected
cells were resuspended in pre-warmed KSFM and dispensed over the culture plates manually.
For 3D culture transfection, 6 million primary human keratinocytes were electroporated with 1 nmol annealed siRNAs, using the
Amaxa human keratinocyte Nucleofector kit (Lonza) according to the manufacturer’s instructions and the program T-018 of the
Amaxa Nucleofector II device. After nucleofection, cells were let to recover for 12-24 hr in KSFM.
siRNA library
145 genes were selected based on differential expression and RPKM over 5 in a dataset published in Kouwenhoven et al., 2015.
Additionally, literature was manually searched to select those factors that had DNA binding capacities. A custom silencer select
siRNA library was obtained fromAmbion including 3 siRNAs per gene divided over 2 plates. The siRNA screenswere performed using
the pooled siRNAs per gene.
Information about individual siRNAs is included in Table S1.
siRNA screening and data processing
Passage 3 foreskin keratinocytes were grown up to 70% confluency in KFSM for nucleofection. In addition to the custom library,
siRNA controls were transfected; scramble siRNAs and siRNAs targeting TGM1. After transfection, the cells were manually
dispensed onto 20 96-well plates, generating quadruplicate plates for each differentiation inducing treatment plus control. The me-
dium was refreshed the next day and after 72 hours and differentiation was induced (vehicle, AG1478, BMP 2/7, AG1478 + BMP 2/7
and serum) for 48 hours. The cells were fixed using 4%paraformaldehyde in PBS (10minutes, at RT) and subsequently permeabilised
using 0.1% Triton X-100 in PBS (10 minutes, at RT). The cells were blocked using 10% serum in PBS for 30 minutes at room tem-
perature and subsequently stained with primary antibody targeting TGM1 (mouse anti-BC-1, 1:2000) for 1 hour at room temperature.
Following 3 washes the cells were stained with mouse secondary antibody IR800 (IRDye 800CW, 1:2000) and DNA staining agent
DRAQ5 (Biostatus, 1:4000) in blocking buffer for 1 hour at room temperature. After three washes a final volume of 100 uL PBS
was added and the plates were scanned using the Li-Cor Odyssey CLx system. The same settings were used for each screen.
Signals were quantified using the Li-Cor OdysseyCLx software and used for subsequent analysis. The signal was normalized using
the DRAQ5 DNA stain and the background signal measured in the TGM1 KD samples was subtracted. The data was further pro-
cessed to z-scores based on knockdown readouts only, transforming the data to a standardized format enabling compilation of
all the experimental data.
Bayesian mixture model and network visualization
The phenotypic profiles extracted from the screen, describing the effect of knockdown of a certain gene on TGM1 expression in
5 different conditions, are compared in this model. The network is visualized using the R-package RedeR (Castro et al., 2012).
The Bayesian mixture model is described in Wang et al. (2012). In short, we extracted the phenotypic profiles per gene from the
z-score matrix, for which the cosine correlation between each gene pair was calculated. Under the assumption that there were three
possible modes of functional association; positive, negative or a lack of association, there are three beta distributions in this model.
To estimate the parameters a and b for the positive and negative distribution, maximum a posteriori probability (MAP) inference was
applied with an uninformative prior (uniform Dirichlet priors) using an expectation maximization (EM) algorithm. For the parameters
of the lack of association distribution, the dataset is permutated 100 times to create a random dataset. The data is fitted to these
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distributions, generating a matrix with probabilities for each gene pair belonging to one of the three distributions. This matrix is sub-
jected to network inference, looking at functional interactions and their signal to noise ratio (SNR: probability positive or negative as-
sociation/probability lack of association). We only considered functional interactions that have a SNR of 10 or higher and checked the
significance of the inferred connections with multiscale bootstrap resampling. Using the approximately unbiased method (sample
size between 0.5 to 1.4), we avoided a bootstrap resampling bias. The displayed p values are defined as 1-AU.
Identification genetic interactions
Cells were transfected with 2 independent siRNAs per gene and the different combinations of these siRNAs in triplicate. RNA was
isolated and CEL-seq 2 libraries were prepared. After sequencing and subsequent mapping using STAR ((Dobin et al., 2013)
RRID:SCR_015899) the data was analyzed using DESeq 2.0 ((Hashimshony et al., 2016) RRID:SCR_015687) to call differentially ex-
pressed genes versus siControl. We included all genes that were detected in at least 90% of the samples and significantly differen-
tially expressedwith p value < 0.05 in at least one comparison. Furthermore, samples in whichmore than 10%of these genes was not
detected were excluded from further analysis to increase the robustness of the statistical analyses. For the remaining samples and
genes, we calculated the fold change (FC) in expression compared to siControl (observed FC). The expected fold changes (NULL
hypothesis in the absence of a functional interaction) were calculated using the product rule (Mani et al., 2008) multiplying the FC
(equivalent to summing the log FC) for the individual knockdown samples for ZMAT2 versus the other genes. To estimate the variation
of the NULL hypothesis, we performed this calculation for all combinations of independent siRNAs and replicates. The expected
FC was then compared to the observed FC using a multiple testing corrected two-sided t test (Benjamini-Hochberg, FDR < 0.01).
Interactions were labeled alleviating when the expected FC was higher than the observed FC and aggravating when the expected
FC was lower than the observed FC.
RNA extraction, RT-qPCR and expression profiling
RNA was isolated using the Quick-RNATM MicroPrep kit from Zymo Research and subsequently 1 mg RNA was converted to
complementary DNA. ThermoMaxima Reverse Transcriptase was used for reverse transcription and the resulting cDNA was diluted
to 5pmol/mL for qPCR using SYBR Green Master mix. Data was normalized using 18 s signal as a control, which was included on
each plate.
For the samples generated for 3D organotypic cultures, total RNA from organotypic skin cultures was isolated using the RNeasy
Plus mini kit (QIAGEN) according to the manufacturer’s instructions. 1 mg total RNA was subjected to reverse transcription with
the iScript cDNA synthesis kit (Biorad). For qRT–PCR measurements, the Takyon Mix (Eurogentec) was used with the CFX96 Touch
Real-Time PCR Detection System (Biorad). Samples were run at least in duplicates and normalized to ribosomal protein L32 mRNA.
Primer sequences are included in Table S1.
Colony formation assay analysis
The cells were blocked using 10% serum in PBS for 30minutes at room temperature and subsequently stained DNA staining DRAQ5
(Biostatus, 1:4000) in blocking buffer for 1 hour at room temperature. After three washes a final volume of PBS was added and the
plates were scanned using the Li-Cor Odyssey CLx system. The images were processed as described in (van Buggenum et al., 2018)
Organotypic human epidermal tissue
For the generation of organotypic human epidermal tissue, 500,000 human keratinocytes that have been nucleofected with siRNAs
were seeded onto a devitalized dermal matrix and raised to the air–liquid interface to initiate stratification and differentiation, as
described previously (Truong et al., 2006; Sen et al., 2010). Cultures were harvested after four days. Half of the tissue was used
for RNA isolation and the other half for cryosectioning.
Immunofluorescence and tissue analysis
Seven micrometer thick cross sections of human organotypic skin cultures were fixed in either 100% acetone or methanol for 10 min
at 20C followed by blocking in PBS with 10% bovine calf serum (BCS) for 20 min at RT. Antibodies were diluted in PBS with 1%
BCS and incubated with the sections for one hour or overnight. The following primary antibodies were used: collagen type VII
(MerckMillipore, MAB1345) at 1:800 dilution, keratin 1 (BioLegend, Poly19052) at 1:300 dilution, and Ki67 (Thermo Fisher Scientific,
RM-9106-S0) at 1:100 dilution. Alexa-555-conjugated goat anti-mouse and goat anti-rabbit IgG (Molecular Probes, 1:300 dilution),
and Alexa 488-conjugated goat anti-rabbit and goat anti-mouse IgG (Molecular Probes, 1:300 dilution) were used as secondary an-
tibodies. Unbound antibodies were washed off with PBS (3 times, 5 min, RT) and nuclei were stained with 4mg/L Hoechst 33342
(ThermoFisherScientific, H1399) in PBS. Finally, slides were mounted in ProLong Gold antifade Mountant (ThermoFisherScientific)
and analyzed with an Axiovert 200M fluorescence microscope and the AxioVision Software (Carl Zeiss).
IP followed by quantitative mass spectrometry
Passage 3 foreskin keratinocytes were grown up to 70% confluency in KFSM before harvesting and counting. Nuclear extracts were
prepared by adding 5 volumes of buffer A (10 mM HEPES KOH pH 7.9, 1.5 mMMgCl2, 10 mM KCl) and incubation of 1 hour on ice.
The cells were centrifuged for 5 minutes at 450 g before lysis by dounce homogenization in 2 volumes cell pellet buffer A with 0,5%
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NP40 and protease inhibitors. Cytoplasmic and nuclear extract were separated by centrifugation at 3200 g for 15 minutes and
collection of cytoplasmic fraction as supernatant. The nuclear pellet was washed with 10 volume PBS and centrifuged at 3200 g
for 5 minutes. Nuclei were resuspended in 2 volumes extraction buffer C (420 mM NaCl, 20 mM HEPES KOH pH 7.9, 20% v/v glyc-
erol, 2 mM MgCl2, 0.2 mM EDTA, 0.5% NP40, 0.5 mM DTT, protease inhibitors) and incubated 2 hours rotating at 4
C. The extract
was centrifuged for 30 minutes at 14.000 rpm and the nuclear extract was collected. Protein concentration was determined using a
Bradford assay.
500 ug nuclear extract was used in an overnight IP with 3 mg a-ZMAT2 (DSHB, RRID:SCR_013527, PRCP-ZMAT2-1E5) in a total
volume of 500 mL. PCRP-ZMAT2-1E5 was deposited to the DSHB by Protein Capture Reagents Program, produced by JHU/CDI
(DSHB Hybridoma Product PCRP-ZMAT2-1E5). This was mixed with 25 mL Dynabeads magnetic beads (Invitrogen) and incubated
for 4 hours rotating at 4C. After incubation, beads where washed three times using buffer A, two times using PBS, once using ABC
buffer (25 mM ammonium bicarbonate) before final resuspension in 50 mL ABC buffer. Overnight digestion was performed using
350 ng trypsin where after samples were desalted using C18 stagetips (Rappsilber et al., 2007).
The tryptic peptides were separated in a 120 minute acetonitrile gradient (7% to 32%, stepwise increase up to 95%) on an Easy
nLC 1000 (Thermo Scientific) connected online to a Orbitrap Fusion Tribrid mass spectrometer. Mass spectrometry and mass spec-
trometry/mass spectrometry spectra were recorded as described in van Buggenum et al., 2018. Data analysis was performed as
described before (Smits et al., 2013) using MaxQuant version 1.5.1.0 (RRID: SCR_014485) (Cox and Mann, 2008) and protein data-
base UniProt_201512yHUMAN. In brief, data was analyzed using default settings of the MaxQuant software package, where after
Perseus was used to filter out reverse hits and to impute missing values. Plots were made in R.
IP-RNA sample preparation
Passage 3 foreskin keratinocytes were grown up to 70% confluency in KFSM before harvesting and counting. After preparing the
nuclear extract and determining the protein concentration by Bradford assay, the extract was divided over samples for input RNA
isolation and IP in triplicate. For input RNA, RNAwas isolated directly from the nuclear extract and stored at20C. IP was performed
as described in the IP-mass spectrometry paragraph up to washing the beads. RNA lysis buffer was added to the beads and incu-
bated for 5 minutes before removing the beads from the sample using the magnetic tray. RNA was isolated from the supernatant as
indicated in the protocol providedwith theQuick-RNATMMicroPrep kit (ZymoResearch). The isolated RNAwas further processed for
sequencing using the CEL-seq 2 library prepation protocol and subsequent analysis.
Epifluorescence localization ZMAT2
Cells were transfected with scramble siRNAs or siRNAs targeting ZMAT2 seeded in 96-well glass bottom plates and cultured for
72 hours as indicated. Cells were washed, fixed using 4% paraformaldehyde for 10 minutes and subsequently permeabilised using
0.3% triton in PBS for 10 minutes. The cells were pre-blocked using 0.2M glycine for 20 minutes and blocked for 1 hour using 1%
BSA. Cells were incubated overnight at 4Cwith primary stain, which included a no-primary-antibody control and 4 mg/mL a-ZMAT2
(DSHB, PRCP-ZMAT2-1E5). After three wash steps with PBS cells were stained with secondary antibody Alexa 488 rabbit a-mouse
(1:2000) for 1 hour and DAPI (1:500) in the last 10 minutes. Cells were washed 3 times and imaged on a Leica DMI6000B automated
high-content microscope.
Library preparation RNA sequencing
RNA sequencing libraries were prepared as described in the protocol supplied with the Illumina KAPA RNA HyperPrep Kit with
RiboErase (HMR) – (KR1351), starting from 500 ng. The concentration of the libraries was determined using the Denovix HS dsDNA
assay and library quality was checked using the Bioanalyser platform (Agilent). Samples were sequenced using the NextSeq500
(Illumina) platform.
CEL-seq 2
CEL-seq 2 libraries were generated using the protocol from (Hashimshony et al., 2016) with the following adaptations. 100pg purified
RNA was directly added to a reverse transcription mixture containing Maxima H Minus (ThermoFisher) reverse transcriptase and
CEL-seq 2 primers with a 6-nucleotide sample barcode and 8-nucleodide UMI. After reverse transcription samples were pooled
and purified using AmpureXP beads (Beckman Coulter). Second strand synthesis was performed according to the original protocol,
libraries were amplified using 2 consecutive PCR reactions.
Data analysis sequencing data
CEL-seq 2 data was processed using the Yanai pipeline (Hashimshony et al., 2016) up to count tables which were further processed
using DESeq 2.0. RNA sequencing data from KAPA RNA HyperPrep kit generated libraries was aligned (hg38, annotation: ensembl
genecode basic annotation V27) and sorted using STAR and analyzed using DEXSeq ((Anders et al., 2012) RRID:SCR_012823). For
the analysis using MISO ((Katz et al., 2010) RRID:SCR_003124) the sequencing data was aligned to hg19 using STAR where after the
collection annotations under theHuman genome (hg19) alternative events v1.0 was used to call alternative events. Data regarding the
siRNA knockdown of ZMAT2 and SRSF1 is deposited in GEO (RRID:SCR_005012) under accession code GSE114529, and data
regarding the induction of differentiation is deposited under accession code GSE117562.
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Expression ZMAT2 in different tissues
Expression of ZMAT2 and other spliceosome components was taken from the EMBL expression atlas, which extracts its raw data
from the PRIDE proteomics database. Website open source database: https://www.ebi.ac.uk/gxa/home/
FACS analysis
Viability, apoptosis and cell cycle state were analyzed using the MUSE Cell Analyzer (EMD Millipore). Cells were counted and sub-
sequently stained usingMUSECount and Viability Reagent (EMDMillipore) as indicated in the protocol for 5minutes. In parallel, cells
were stained using annexinV-PE (BD, 1:25 in PBS) for 15 minutes before analysis on the MUSE Cell Analyzer (EMD Millipore). Pre-
programmed software allowed easy setting of the gates in the Count and Viability protocol and the AnnexinV and Cell Death protocol.
For cell cycle analysis, cells were counted, fixed using 70%ethanol overnight at20Cand stained using 50 mg/mL propidium iodide,
100 ug/mL RNase A, 0,1% Triton and 0,1% BSA in PBS for 1 hours at room temperature. Pre-programmed software was used to set
the gate in the Cell Cycle Assay protocol.
QUANTIFICATION AND STATISTICAL ANALYSIS
Quantification and statistical analysis was performed as described in the sections describing the applied techniques. Statistical tests
and parameters were performed as reported in the appropriate figure legends and sections of the manuscript.
DATA AND SOFTWARE AVAILABILITY
Data resources
The accession numbers for the RNA sequencing data reported in this paper are GEO (RRID:SCR_005012): GSE114529 (siRNA
knockdown of ZMAT2 and SRSF1) and GSE117562 (induction of differentiation). The data that was generated in the siRNA screen
and subsequent processing steps can be found in Data S1.
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